Eurofarma Laboratórios S.A. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net income was BRL 139.75 million compared to BRL 110.91 million a year ago. Basic earnings per share from continuing operations was BRL 0.16273 compared to BRL 0.12916 a year ago. Diluted earnings per share from continuing operations was BRL 0.16273 compared to BRL 0.12916 a year ago.
For the six months, net income was BRL 450.44 million compared to BRL 415.21 million a year ago. Basic earnings per share from continuing operations was BRL 0.52454 compared to BRL 0.48352 a year ago. Diluted earnings per share from continuing operations was BRL 0.52454 compared to BRL 0.48352 a year ago.